Contineum Therapeutics (CTNM) Tax Rate (2023)

Contineum Therapeutics (CTNM) recorded quarterly Tax Rate of 2.03% in Q4 2023, up 29.31% quarter-over-quarter from 1.57% in Q3 2023.

Contineum Therapeutics (CTNM) Tax Rate (2023) Analysis & Trends

Contineum Therapeutics' Tax Rate history runs 1 years deep, the most recent figure standing at 2.03% for Q4 2023.

In Q4 2023, Tax Rate changed N/A year-over-year to 2.03%; the TTM figure through Sep 2024 stood at 0.45% (changed N/A YoY), while the FY2023 annual figure was 1.94%, changed N/A from the prior year.
Tax Rate was 2.03% for Q4 2023 at Contineum Therapeutics, up from 1.57% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 2.03% in Q4 2023 to a low of 1.57% in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-57.14%
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	5.61%
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-6.79%
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	17.68%
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	Contineum Therapeutics	423.05 Mn	423.05 Mn	-	-

Download Data